[The effect of retabolyl on the lipid and protein metabolism of coronary atherosclerosis patients].
D000328:Adult; D000368:Aged; D045930:Anabolic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D000924:Anticholesteremic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001161:Arteriosclerosis / Q000188:drug therapy* / Q000378:metabolism; D002784:Cholesterol / Q000097:blood; D003327:Coronary Disease / Q000188:drug therapy* / Q000378:metabolism; D005260:Female; D006801:Humans; D050356:Lipid Metabolism; D008074:Lipoproteins / Q000097:blood / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D010743:Phospholipids / Q000097:blood / Q000378:metabolism; D011506:Proteins / Q000378:metabolism*
D045930:Anabolic Agents; D000924:Anticholesteremic Agents; D008074:Lipoproteins; D010743:Phospholipids; D011506:Proteins; D002784:Cholesterol
Vliianie ratabolila na lipidnyĭ i belkovyĭ obmen u bol'nykh koronarnym aterosklerozom.